Description
Overview
The Cleveland Clinic Heart Failure Summit Expanding the Frontiers of Contemporary Team Management 2025 is an in-depth digital course designed for healthcare professionals focused on advanced heart failure management. This comprehensive program delivers current strategies and emerging therapies to support clinical decision-making in heart failure care.
On-demand cardiology education — accessible anytime, anywhere.
Format: 7 videos, 38 PDFs
Total size: 2.21 GB
Agenda
This course includes a broad range of sessions addressing practical and evolving aspects of heart failure diagnosis, treatment, and team-based management.
- Advanced evaluation of the breathless patient
- AF ablation and the pulsed field era
- Arrhythmogenic cardiomyopathies and genetic testing
- Breakthroughs in obesity-related HFpEF
- Cardiac contractility modulation
- Current and emerging device-based therapies for HFpEF
- Educating and engaging the patient of tomorrow
- GDMT optimization across the inpatient-outpatient domain
- Harnessing tech for GDMT optimization and readmission reduction
- Harnessing the heart team for GDMT equity
- HF STATS: The changing face of heart failure
- Lessons learnt for diverse HF trial recruitment
- New insights into HFpEF mechanisms
- Novel therapies for cardiomyopathies
- Remote monitoring in the “AI era” – Leveraging new devices and algorithms
- Remote monitoring the “old school” way – Weights, vitals and symptoms
- Session 1 – Updates in HF Epidemiology and Population Health
- Session 2 – HFrEF and EP Innovations
- Session 3 – HFpEF and Pulmonary Hypertension
- Session 4A – Meet the Clinical Trialists (Concurrent Session)
- The future of remote HF and EP monitoring
- The LAA and controversies in anticoagulation
- The next frontier – earlier diagnosis and treatment of HF
- The next generation HFrEF therapies
- Trials and tribulations in valvular interventions
- Ventricular tachycardia in patients with HFrEF
- What’s new in pulmonary hypertension
- A positive PET scan – What comes next
- Collapse to comeback – Improving outcomes after cardiac arrest
- DanGer ahead – Seeking an evidence base for shock management
- Evolutions in organ preservation and transportation
- Fixing the flow – Revascularization for the high-risk patient
- Getting shock right – Managing the right ventricle
- HCM in the era of myosin inhibition
- LVADs in a Transplant World
- Managing MCS at a non-transplant center
- Managing TTR cardiac amyloidosis in 2025
- Multidisciplinary cardiac care during pregnancy
- Post-heart transplant outcomes and management innovations
- Session 1 – Cardiomyopathies (amyloid, HCM, Sarcoid) and HFrEF
- Session 2 – MCS and TX
- Session 3 – Cardiogenic shock and critical care
- The next generation of LVADs and trials
- Transplant and VAD options in congenital conditions
Learning Objectives
- Apply appropriate strategies to optimize current and novel drug therapies for heart failure with reduced left ventricular ejection fraction
- Describe utilization of medical devices and surgical therapies in heart failure patient care
- Distinguish clinical profiles of heart failure with reduced versus preserved ejection fraction
- Review latest pharmacological approaches to heart failure with midrange or preserved ejection fraction
- Employ therapeutic strategies for cardiac amyloidosis and hypertrophic cardiomyopathy
- Identify electrophysiological interventions for managing sudden death risk and atrial arrhythmias in heart failure patients
Speakers
This activity features expert discussions and presentations from leading clinicians and researchers in cardiology specializing in heart failure management and innovative therapies. The faculty bring diverse perspectives from clinical practice and research settings to support comprehensive learning.
Target Audience
This course is intended for cardiologists, internists, primary care physicians, physician assistants, pharmacists, nurse practitioners, nurses, and other healthcare professionals involved in the care and management of patients with heart failure.
Why This Topic Matters
The Cleveland Clinic Heart Failure Summit Expanding the Frontiers of Contemporary Team Management 2025 addresses critical advancements essential for cardiology specialists managing complex heart failure cases. Staying informed on evolving therapeutic options and multidisciplinary approaches is crucial in this specialty.
MedHub Central supports clinicians by providing on-demand access to expert-led education, enabling healthcare professionals to enhance their expertise in heart failure treatment and optimize patient care within their clinical practice.
